The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2013.00419
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Tolerogenic Dendritic Cells for Therapy of Immune-Mediated Inflammatory Diseases

2012English

Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications

Immune Network
Infectious DiseasesImmunologyAllergy
2016English

Cancer Cell Immune Escape and Tumor Progression by Exploitation of Anti-Inflammatory and Pro-Inflammatory Responses

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2005English

Semen Promotes the Differentiation of Tolerogenic Dendritic Cells

Journal of Immunology
AllergyImmunology
2012English

Chloroquine-Treated Dendritic Cells Require STAT1 Signaling for Their Tolerogenic Activity

European Journal of Immunology
AllergyImmunology
2018English

Tolerogenic Effect of Mouse Fibroblasts on Dendritic Cells

Immunology
AllergyImmunology
2016English

How Tolerogenic Dendritic Cells Induce Regulatory T Cells

Advances in Immunology
2010English

Tolerogenic Versus Inflammatory Activity of Peripheral Blood Monocytes and Dendritic Cells Subpopulations in Systemic Lupus Erythematosus

Clinical and Developmental Immunology
2012English

P138/O10 Investigating Gene Expression Patterns and Function of Tolerogenic Dendritic Cells

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy